Handelsavisen
prelaunch
AV
AVD NYSE Chemicals

American Vanguard Corp

$2,46
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
70,5M USD
P/E
EV / Rev
0,7x
Div yield
Op margin
1,5 %
ROE
-2,2 %
Net margin
-3,4 %
Debt / equity
1,41
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

American Vanguard Corp is a diversified agrochemical and specialty products company that develops, produces, and markets crop protection and animal health products, primarily in the United States and internationally. The company generates revenue through the sale of its products, including herbicides, insecticides, and fumigants, as well as through its closed delivery systems such as SmartBox Plus, Lock 'n Load, and EZ Load.

Business. American Vanguard Corp (NYSE: AVD) is a chemicals company operating within the Basic Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification99 %
SectorBasic Materials
Industry groupChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-2,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AVD.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AVD. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    American Vanguard Corp (NYSE: AVD) is a chemicals company operating within the Basic Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification99 %
    SectorBasic Materials
    Industry groupChemicals
    AI synthesis
    GENERATED

    ### Capital Structure and Liquidity American Vanguard Corp has a market capitalization of $85.37 million and a price-to-book ratio of 1.59, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized as medium, with a current ratio of 2.32, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's operating cash flow was negative at -$35.44 million for the quarter, indicating a cash outflow from operations.

    ### Profitability and Returns The company's profitability is weak, with a net loss of -$4.15 million for the quarter and a return on equity of -2.19%. The return on assets is also negative at -0.62%, indicating that the company is not generating returns that exceed its cost of capital. The gross profit margin is 31.1%, which is in line with industry norms, but the operating margin is only 1.53%, reflecting high operating expenses relative to revenue.

    ### Segments and Geographic Exposure American Vanguard Corp operates in multiple geographic regions, with a significant portion of its revenue derived from the United States. The company's exposure to international markets is limited, with operations in countries such as Canada, Mexico, and other foreign jurisdictions. The company's revenue concentration in the U.S. may expose it to domestic economic and regulatory risks.

    ### Growth Trajectory The company's growth trajectory is uncertain, with a net loss in the most recent quarter and a negative operating cash flow. The company's ability to grow revenue is constrained by factors such as product liability claims, regulatory challenges, and competition from generic products. The company's debt structure, including a long-term debt of $264.38 million, may also limit its ability to invest in growth opportunities.

    ### Risk Factors The company faces several risk factors, including product and environmental liability, regulatory challenges, and the impact of economic conditions. The company's dependence on suppliers and global supply chain disruptions could also affect its operations. Additionally, the company's new debt structure and the ability to borrow under its credit facility are critical to its financial stability. The company has also identified material weaknesses in its internal controls over financial reporting, which could affect the accuracy of its financial statements.

    ### Recent Events Recent events include the adoption of new accounting guidance related to credit losses and the filing of a 10-K report that details the company's financial position and risk factors. The company has also been involved in legal proceedings related to product liability and environmental issues. The company's recent financial performance, including a net loss and negative operating cash flow, highlights the challenges it faces in maintaining profitability.

    Key takeaways
    • American Vanguard Corp has a weak profitability profile, with a net loss and negative return on equity.
    • The company's liquidity position is moderate, with a current ratio of 2.32, but it has a negative operating cash flow.
    • The company's revenue is concentrated in the United States, which may expose it to domestic economic and regulatory risks.
    • The company's growth is constrained by regulatory challenges, product liability claims, and competition from generic products.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    American Vanguard Corp ranks best-in-class for cash conversion within the Chemicals cohort, significantly outperforming the median.

    The company maintains a current ratio of 1.77, indicating sufficient short-term liquidity to cover immediate obligations.

    Gross profit improved to $147.6 million in FY2025, demonstrating resilience in core production margins despite operating losses.

    BEAR CASE · 4

    American Vanguard Corp faces high credit risk, signaling significant concerns regarding its ability to meet debt obligations.

    Net income plummeted to a $126.3 million loss in FY2025, reflecting a severe deterioration in overall profitability.

    The debt-to-equity ratio of 1.41 places the company in the bottom quartile of its Chemicals cohort peers.

    Operating income collapsed to a $101.6 million loss in FY2025, highlighting substantial inefficiencies in core business operations.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue $123.6M; Operating income $1.9M.

    Revenue$123.6M
    Operating income$1.9M
    Net income-$4.1M
    Free cash flow
    EPS
    Operating cash flow-$35.4M
    Financials
    Income statement
    Revenue$123.6M
    Gross profit$38.4M
    Operating income$1.9M
    Net income-$4.1M
    Margins
    Gross margin31.1%
    Operating margin1.5%
    Net margin-3.4%
    FCF margin
    Balance sheet
    Total assets$665.2M
    Total liabilities$475.6M
    Total equity$189.6M
    Cash & equivalents
    Long-term debt$264.4M
    Cash flow
    Operating cash flow-$35.4M
    CapEx
    Free cash flow
    SBC$186.0k
    P&L flow · revenue → net income
    Revenue $123.6MOperating costs $121.7MTax $6.0MNet income $4.1M
    Highlights
    • Revenue $123.6M
    • Operating income $1.9M
    • Net margin -3.4%

    Valuation FY

    Market price
    $2,46
    Market cap
    $85.4M
    Enterprise value
    $352.0M
    P/E
    Non-GAAP P/E
    EV / Revenue
    0.7x
    EV / Op income
    EV / OCF
    P / B
    1.6x
    P / Tangible book
    1.6x
    Tangible book
    $53.5M
    Net cash
    -$266.6M
    Current ratio
    2.3
    Debt / equity
    1.4
    ROA
    -0.6%
    ROE
    -2.2%
    Cash conversion
    855.0%
    CapEx / revenue
    SBC / revenue
    0.1%
    Dilution ratio

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    Op Margin1,5 %Below median
    Net Margin-3,4 %Bottom quartile
    ROE-2,2 %Below median
    D/E1,41Bottom quartile
    Cash Conv8,55Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 170 000 sh7 grants7 insiders
    • Straley JaredSVP Operations & Supply Chain · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
    • Khosravi ShirinCHRO · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
    • Gilliam NolteanousSVP Manufacturing · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
    • Donnelly Timothy JSee Remarks · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
    • Johnson David` T.See Remarks · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
    • Kaye DouglasDirector, CHIEF EXECUTIVE OFFICER · Option to Buy → Common StockAcquired 50 000 @ $2,51grant · 2026-06-04
    • DiPaola Michael JosephChief Commercial Officer · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • AMERICAN VANGUARD CORP company facts · 2026-05-27
    • AMERICAN VANGUARD CORP 10-Q 2026-05-06 · 2026-05-27
    • AMERICAN VANGUARD CORP 10-K 2026-03-16 · 2026-05-27
    • AMERICAN VANGUARD CORP 10-Q 2025-11-10 · 2026-05-27
    • AMERICAN VANGUARD CORP 10-Q 2025-07-31 · 2026-05-27

    Ownership & reference

    Leadership

    • Eric G. WintemuteChairman of the Board, Chief Executive Officer

    Insider activity

    Net buying4 buys · 1 sellsnet $165K9 insiders · last 365d
    • Kaye DouglasCHIEF EXECUTIVE OFFICER · Common StockOther 6 527 @ $2,36$15K · 2026-07-10
    • Angelini MarisolDirector · Common StockOther 31 872 · 2026-06-04
    • Bassett Mark RDirector · Common StockOther 31 872 · 2026-06-04
    • ROSENBLOOM KEITH MDirector · Common StockOther 31 872 · 2026-06-04
    • McDougal Rubin JDirector · Common StockOther 31 872 · 2026-06-04
    • Gottschalk Patrick EDirector · Common StockOther 31 872 · 2026-06-04
    • Macicek Steven DDirector · Common StockOther 31 872 · 2026-06-04
    • Kaye DouglasCHIEF EXECUTIVE OFFICER · Common StockBought 5 000 @ $2,50$12K · 2026-06-03
    • Gottschalk Patrick EDirector · Common StockBought 25 000 @ $2,70$68K · 2026-05-19
    • Gottschalk Patrick EDirector · Common StockBought 20 000 @ $2,95$59K · 2026-05-13
    • Gottschalk Patrick EDirector · Common StockBought 20 000 @ $2,92$58K · 2026-05-12
    • Kaye DouglasCHIEF EXECUTIVE OFFICER · Common StockOther 4 790 @ $3,26$16K · 2026-01-29
    • ROSENBLOOM KEITH MDirector · Common StockOther 217 503 · 2025-11-26
    • Bassett Mark RDirector · Common StockOther 23 636 · 2025-11-26
    • Gottschalk Patrick EDirector · Common StockOther 47 281 · 2025-11-26
    • Eilers PeterSee Remarks · Common StockSold 6 000 @ $5,35$32K · 2025-09-04
    • Tiu de Mino CarmenDirector · Common StockOther 17 621 · 2025-08-07
    • ROSENBLOOM KEITH MDirector · Common StockOther 17 621 · 2025-08-07
    • Bassett Mark RDirector · Common StockOther 17 621 · 2025-08-07

    Short positioning

    210.2Kshares short-11.8% vs prior
    1days to cover
    80.0%short of daily vol
    4fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AVDCanonical
    NYSE · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.3%Derived (calculated)
    • Net margin (FY 2025-12-31): -9.7%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 72.1%Derived (calculated)
    • Gross margin (FY 2025-12-31): 28.6%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 18.1%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 61.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -640.2%Derived (calculated)
    • Return on assets (FY 2025-12-31): -8.4%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 60.0%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.77xDerived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -29.1%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): -5.9%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 22.6%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 0.1%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -13.9%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 61.1%Derived (calculated)
    • EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
    • Net income (annual): USD -49.88MSEC XBRL filing
    • Interest expense (annual): USD 18.47MSEC XBRL filing
    • Revenue (annual): USD 515.11MSEC XBRL filing
    • Current assets (annual): USD 370.52MSEC XBRL filing
    • Total assets (annual): USD 596.54MSEC XBRL filing
    • Total liabilities (annual): USD 404.14MSEC XBRL filing
    • Operating income (annual): USD -28.3MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-30EVENTQ2 2026 earnings (expected) estimated date
    2026-07-10INSIDERKaye Douglas transacted 6.5k sh — CHIEF EXECUTIVE OFFICER ~$15k
    2026-06-08FILING8-K filing →
    2026-06-04 00:00 UTCINSIDER14 insider transactions — 2026-06 7 derivative
    2026-06-04INSIDERAngelini Marisol transacted 31.9k sh — Director
    2026-06-04INSIDERBassett Mark R transacted 31.9k sh — Director
    2026-06-04INSIDERROSENBLOOM KEITH M transacted 31.9k sh — Director
    2026-06-04INSIDERMcDougal Rubin J transacted 31.9k sh — Director
    2026-06-04INSIDERGottschalk Patrick E transacted 31.9k sh — Director
    2026-06-04INSIDERMacicek Steven D transacted 31.9k sh — Director
    2026-06-04INSIDERKhosravi Shirin acquired 20.0k sh Option to Buy — CHRO
    2026-06-04INSIDERDonnelly Timothy J acquired 20.0k sh Option to Buy — See Remarks
    2026-06-04INSIDERJohnson David` T. acquired 20.0k sh Option to Buy — See Remarks
    2026-06-04INSIDERKaye Douglas acquired 50.0k sh Option to Buy — Director, CHIEF EXECUTIVE OFFICER
    2026-06-04INSIDERDiPaola Michael Joseph acquired 20.0k sh Option to Buy — Chief Commercial Officer
    2026-06-04INSIDERStraley Jared acquired 20.0k sh Option to Buy — SVP Operations & Supply Chain
    2026-06-04INSIDERGilliam Nolteanous acquired 20.0k sh Option to Buy — SVP Manufacturing
    2026-06-03INSIDERKaye Douglas bought 5.0k sh — CHIEF EXECUTIVE OFFICER ~$12k
    2026-05-19 00:00 UTCINSIDER3 insider transactions — 2026-05 · net buy $185k
    2026-05-19INSIDERGottschalk Patrick E bought 25.0k sh — Director ~$68k
    2026-05-13INSIDERGottschalk Patrick E bought 20.0k sh — Director ~$59k
    2026-05-12INSIDERGottschalk Patrick E bought 20.0k sh — Director ~$58k
    2026-05-06FILING10-Q filing →
    2026-04-23FILINGDEF 14A filing →
    2026-04-15FILING8-K filing →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Revenue USD 123.6M · Net USD -4.1M
    2026-03-19FILING8-K filing →
    2026-03-18FILING8-K filing →
    2026-03-16FILING10-K filing →
    2026-01-29 00:00 UTCINSIDER1 insider transaction — 2026-01
    2026-01-29INSIDERKaye Douglas transacted 4.8k sh — CHIEF EXECUTIVE OFFICER ~$16k
    2025-12-31EARNINGSQuarterly results — Q3 2025
    2025-12-31EARNINGSAnnual results — FY 2025 Revenue USD 515.1M · Net USD -49.9M
    2025-11-26 00:00 UTCINSIDER3 insider transactions — 2025-11
    2025-11-26INSIDERROSENBLOOM KEITH M transacted 217.5k sh — Director
    2025-11-26INSIDERBassett Mark R transacted 23.6k sh — Director
    2025-11-26INSIDERGottschalk Patrick E transacted 47.3k sh — Director
    2025-11-12FILING8-K filing →
    Showing the 40 most recent of 54 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage